Week of November 8th 2021 | Vol. 10, Issue 45
In This Issue
Featured Headlines
Recent Industry Transactions
Industry Trading Comps
Recent Industry Headlines
Market Reports
Upcoming Events

Quick Links

Contact Information
Managing Director
Business Development

Managing Director
Head of M&A and Capital Advisory

Above is an overview of recent industry M&A activity. For additional information, see the charts below or click on the chart above to download complete transaction tables broken out by industry sub sectors.

For more information about our consumer healthcare JV with The Emerson Group, Daybreak Consumer Care, click here.
Recent Materials Providing Insight Into Healthcare Related Industries
Current M&A Pipeline
Representative Current Retained Sell-Side And Partnering Opportunities
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Alamo
Sell-side | CMO | Corporate Carve out - private label and OTC manufacturing business

Project Focus
Sell-side | CMO | Liquids and Semi-solids CMO headquartered in North America

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics

Project Aspen
Sell-side | CDMO | Multinational CDMO headquartered in US

Project Athena
Sell-side / Licensing | Medical Device | Novel device for pelvic organ prolapse
By all measures, 2021 has been a time of extraordinary challenges for healthcare workers and executives. This is especially true for women in the industry.

Even before the pandemic, female physicians and researchers earned less, did more at home and tended to be lower on the professional ladder compared with men. The COVID-19 pandemic has had profound and far-reaching impacts on healthcare workers in the U.S. This burden has, in many ways, been disproportionately shouldered by women.

But there are significant shifts happening in the industry. Solving health emergencies like COVID-19 demands creative thinking by the best minds the world has to offer, and women have played a critical role in the pandemic response. Women in healthcare have notched spectacular accomplishments and demonstrated stellar leadership at every level of medicine.
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
Pharma & Biotech
11 transactions totaling $568 million
Supplies, Equipment & Services
8 transactions totaling $1 million
Healthcare IT & Managed Care
4 transactions totaling $48 million
Healthcare Facilities & Distributors
5 transactions
Pharma & Biotech
22 transactions totaling $509 million
Supplies, Equipment & Services
11 transactions totaling $369 million
Healthcare IT & Managed Care
10 transactions totaling $228 million
Healthcare Facilities & Distributors
4 transactions
Pharma & Biotech
24 transactions totaling $1,688 million
Supplies, Equipment & Services
2 transactions
Healthcare IT & Managed Care
1 transaction totaling $750
Healthcare Facilities & Distributors
0 transactions
A Breakdown of Relevant Trading Multiples
Each week, we provide updated trading comps for leading companies from numerous healthcare sub-sectors.
To the right you will see a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
A Sampling of Relevant Industry Headlines from Last Week
Below are snippets from relevant industry news articles from the past week. For additional information or the article's complete text, click the headline link to view the original publication.
November 2, 2021 - Fierce Healthcare
Medical software developer Kareo and healthcare marketing company PatientPop have merged to create Tebra, an all-in-one digital platform that supports practices in acquiring and serving patients, the companies announced Tuesday. With Tebra, providers can access PatientPop’s services to grow their practice and gain new patients alongside Kareo’s clinical software for electronic health records and billing. Together, Kareo and PatientPop as Tebra will have access to more than 100,000 providers with more than 85 million patients, according to a statement by the companies.

November 2, 2021 - Fierce Healthcare
Jefferson Health has acquired the remaining 50% stake in Health Partners Plans (HPP) from Temple University Health System for $305 million, now making it the sole owner of the nearly 290,000-person managed care plan. Announced Monday, the deal makes good on a 2019 agreement between Jefferson and Temple. Jefferson had already acquired a quarter of HPP through its acquisition of Aria Health System in 2016 and its more recent merger with Einstein Healthcare Network. The Philadelphia-based health system said its purchase will springboard a push toward value-based care and reduce the costs of healthcare services for plan members.

November 2, 2021 - Fierce Biotech
When it comes to refining current genetic sequencing practices and technologies, there’s no need to completely reinvent the wheel. Take it from Cambridge Epigenetix, which is designing tech that integrates into existing sequencing platforms, expanding their DNA analysis capabilities without forcing researchers to install an entirely new system in their labs. This business model has drawn plenty of support. Cambridge Epigenetix recently closed its series D funding round with a total of $88 million, bringing its lifetime fundraising total to nearly $150 million.

November 4, 2021 - Fierce Biotech
Several lucky startups developing new technologies to transform the medical field are about to get quite a bit richer—$740 million richer, to be exact. San Diego-based venture capital firm Section 32 said this week that it closed its fourth fund with nearly three-quarters of a billion dollars, ready to be doled out to companies in its target areas of tech, healthcare and the intersection of the two. Fund 4, the latest in a list of funding pools that have grown increasingly larger since Section 32 launched in 2017 with its first $100 million fund, brings the firm’s total assets to more than $1.8 billion.
Events Hosted or Attended by Bourne Partners

Dates TBD - Charlotte, NC

November 2, 2021 - Virtual Webinar

November 9-11, 2021 - Milan, Italy

January 10-14, 2022 - San Francisco, CA

July-September, MAP distributed over 4,800 units of Tanner donated medicines to support children in 6 countries across the globe.
Key directors from our team will attend CPhI and several other international healthcare conferences throughout Nov and Dec. Let’s connect!

Discover what’s possible with Tanner’s Global Access Solutions.
Welcome to Bourne, let's talk.

Since our founding in 2001, Bourne Partners has remained focused on fulfilling the unique needs of established, middle-market healthcare and pharmaceutical companies across the globe. Our track record includes advising middle market companies in healthcare M&A assignments totaling more than $7 billion, and growing companies into successful and well-positioned pharmaceutical enterprises.